Compounding pharmacies producing cheaper semaglutide products have been given notice they will soon have to stop, as the drug ...
The semaglutide shortage has officially ended in the US—which means the GLP-1 drug industry is about to undergo massive ...
Feb. 21, the Food and Drug Administration said there is no longer a short supply of the weight loss and diabetes drugs Wegovy ...
The shortage of Novo Nordisk’s (NVO) blockbuster diabetes and weight-loss drugs is officially over, according to the U.S.
The FDA’s recent approval of OZEMPIC highlights the expanding use of GLP-1 drugs beyond diabetes and weight management. Novo Nordisk’s blockbuster medication has gained another label expansion, now ...
Ozempic may also help people drink less alcohol. Primary care doctors are concerned about patients accessing GLP-1s through third-party telehealth providers.
Kwame Raoul is among several state AGs raising the alarm following complaints about online teleheath company Hims & Hers ...
The FDA approved the denosumab biosimilar Ospomyv, interchangeable with Prolia, for preventing osteoporosis-related fracture ...